EVAR术后腹主动脉瘤囊缩小与胸主动脉夹层样形态相关
本研究纳入1996–2017年在Mount Sinai医院接受EVAR的腹主动脉瘤患者,比较有或无胸主动脉夹层样形态(夹层、穿透性溃疡、壁内血肿)者的瘤囊变化。结果显示有夹层样形态者瘤囊缩小更明显,且II型内漏更少,但3年AAA相关死亡率无差异。
要点
- 胸主动脉夹层样形态与EVAR术后更大的腹主动脉瘤囊缩小相关。
- 有夹层样形态者术后II型内漏发生率更低(22.9% vs 53.9%)。
- 两组3年AAA相关死亡率无显著差异。
核心结论
- 胸主动脉影像学夹层样形态与EVAR术后更大的AAA瘤囊缩小和更少的II型内漏相关。
- 评估这些影像特征可能有助于理解EVAR术后动脉瘤行为及预后。
研究设计与样本
- 回顾性队列研究,纳入1996–2017年Mount Sinai医院因肾下腹主动脉瘤行EVAR且有术后CT及3年随访CT的患者。
- 排除I型或III型内漏患者,比较有夹层样形态(n=157)与无夹层样形态(n=141)患者的AAA瘤囊变化。
- CT分析由独立研究者完成,且对瘤囊缩小程度设盲。
主要发现
- 有夹层样形态者EVAR术后中位AAA直径变化为-11.30 mm(-17.20, -3.60),无夹层样形态者为0.30 mm(-8.60, 8.60)(p < 0.001)。
- 有夹层样形态者术后随访CT中II型内漏更少(22.9% vs. 53.9%,p < 0.001)。
- 有夹层样形态者EVAR手术时间更长(192.00 min [167.25, 230.00] vs. 174.00 min [150.00, 215.00],p = 0.004)。
- 两组3年AAA相关死亡率无显著差异(p = 1.0)。
- 两组在年龄、性别、吸烟习惯或心血管疾病方面无显著差异。
关键数值与推荐
- 夹层样形态定义为CT上存在主动脉夹层、穿透性主动脉溃疡和壁内血肿。
- 有夹层样形态者中位AAA直径变化-11.30 mm(-17.20, -3.60),无夹层样形态者0.30 mm(-8.60, 8.60),p < 0.001。
- II型内漏发生率有夹层样形态者22.9%,无夹层样形态者53.9%,p < 0.001。
- EVAR手术时间有夹层样形态者192.00 min(167.25, 230.00),无夹层样形态者174.00 min(150.00, 215.00),p = 0.004。
- 3年AAA相关死亡率两组比较p = 1.0。
临床怎么用
- 对于接受EVAR的AAA患者,可评估胸主动脉CT上的夹层样形态以预判瘤囊缩小程度和II型内漏风险。
- 夹层样形态的存在可能与更佳的瘤囊缩小相关,但需结合其他因素综合判断。
- 该发现提示亚临床夹层在AAA发展病因学中可能发挥作用,但仍需进一步研究。
局限性
- 研究为单中心回顾性设计,可能存在选择偏倚。
- 样本量有限,有夹层样形态者157例,无夹层样形态者141例。
- 仅纳入有3年随访CT的患者,可能引入随访偏倚。
- 排除I型或III型内漏患者,结论不适用于这些人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aneurysm sac regression following endovascular repair (EVAR) of an abdominal aortic aneurysm (AAA) is an established indicator of surgical success. However, even with a completely excluded aneurysm, the degree of aortic sac regression may vary. This study evaluates the relationship between aneurysm sac regression after EVAR and the presence of morphological features in the thoracic aorta that can be associated with a subclinical aortic dissection, termed dissection morphology in this study. METHODS: Patients who underwent EVAR to repair an infrarenal aortic aneurysm at Mount Sinai Hospital between 1996 and 2017 with a postoperative CT scan and a 3-year follow-up scan available for analysis were included in the study. Patients with a type I or type III endoleak were not included. The thoracic aorta was evaluated for dissection morphology on CT scan, which included the presence of aortic dissection, penetrating aortic ulcers, and intramural hematomas. AAA sac regression after EVAR was compared between patients with dissection morphology (n = 157) and patients without those characteristics (n = 141). An independent investigator performed the CT analysis and was blinded to the degree of sac regression. RESULTS: Demographics and comorbid clinical conditions were compared between patients with and without dissection morphology. There were no significant differences in age, gender, smoking habits, or cardiovascular conditions. The median AAA diameter after EVAR, over the course of the study, in patients with dissection morphology decreased by 11.30 mm (-17.20, -3.60) compared to a median change of 0.30 mm (-8.60, 8.60) in patients without dissection morphology features (p < 0.001). Patients with dissection morphology also had fewer type II endoleaks in postoperative follow-up scans (22.9% vs. 53.9%, p < 0.001). Additionally, patients with dissection morphology had longer EVAR operative times (192.00 min [167.25, 230.00] vs.174.00 min [150.00, 215.00], p = 0.004). AAA-related mortality after 3 years was not significantly different between the 2 groups (p = 1.0). CONCLUSIONS: The presence of imaging features consistent with dissection morphology in the thoracic aorta correlated with greater AAA sac regression and fewer type II endoleaks after EVAR. Assessing these imaging features in patients undergoing EVAR may be useful in understanding aneurysm behavior in terms of aneurysm growth, risk of rupture, and outcomes following endovascular surgery. Identifying differential rates of aneurysm sac regression may have implications regarding the role of subclinical dissections in the etiology of AAA development.
引用
- Miner GH, Taubenfeld E, Tadros RO, et al. Decreased Abdominal Aortic Aneurysm Size Following EVAR in Patients With CT Evidence of Subclinical Thoracic Aortic Dissection. Ann Vasc Surg. 2019. PMID: 31706995. doi:10.1016/j.avsg.2019.10.091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。